Clinical Trial

Apple Vision Pro-Assisted Vascular Identification in Lung Surgery

Study acronym: AVP-Lung
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is testing whether a new mixed-reality head-mounted display (Apple Vision Pro) can help surgeons see blood vessels more clearly during lung surgery. During the operation, doctors usually need to identify and protect important blood vessels to avoid bleeding. In this study, surgeons will wear the Apple Vision Pro device, which shows 3D images of the lungs and blood vessels. This may help them find vessels more accurately and make surgery safer. Participants scheduled for lung surgery at Huai'an Second People's Hospital will be invited to join. Before the operation, participants will have a CT scan. During surgery, doctors will use the device while performing the procedure. The study does not change the standard surgical steps, and there are no extra risks for participants. The main goal is to see if this new technology makes surgery easier and safer. Participation is voluntary, and all personal information will be kept confidential.
Trial Details
NCT Number NCT07573748
Lead Sponsor The Second People's Hospital of Huai'an
Conditions Lung Neoplasms, Mixed Reality
Enrollment 20 participants
Start Date 2026-05-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-07